Back

Intra-Cellular Therapies Quote, Financials, Valuation and Earnings

Election Shock on August 19th?

Click here now to see the evidence I've gathered.

Sell

ITCI
Intra-Cellular Therapies

Last Price:

73.33

Seasonality Move:

4.56%

7 Day Trial

ALL ACCESS PASS

$ 7

BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty

Click here now to prepare yourself for what's around the corner

Intra-Cellular Therapies Price Quote

$73.33

+0.07 (+1.66%)

(Updated: April 27, 2024 at 6:09 AM ET)

Intra-Cellular Therapies Key Stats

Sell

Intra-Cellular Therapies (ITCI) is a Sell

Day range:

$71.66 - $73.52

52-week range:

$45.50 - $84.89

Dividend yield:

P/E ratio:

0.00

P/S ratio:

15.20

P/B ratio:

11.99%

Volume:

573K

Avg. volume:

1.1M

1-year change:

20.02%

Market cap:

$7.1B

Revenue:

$462.2M

EPS:

$-1.46

How Much Does Intra-Cellular Therapies Make?

How Much Are Intra-Cellular Therapies's Sales Annually?
ITCI Revenues are $462.2M
How Much Profit Does Intra-Cellular Therapies's Make A Year?
ITCI net income is -$139.7M

Is Intra-Cellular Therapies Growing As A Company?

What Is Intra-Cellular Therapies's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.5%
What Is Intra-Cellular Therapies's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Intra-Cellular Therapies Stock Price Performance

Did Intra-Cellular Therapies Stock Go Up Last Month?
Intra-Cellular Therapies share price went up by 8.81% last month
Did ITCI's Share Price Rise Over The Last Year?
ITCI share price rose by 20.02% over the past 1 year

What Is Intra-Cellular Therapies 52-Week High & Low?

What Is Intra-Cellular Therapies’s 52-Week High Share Price?
Intra-Cellular Therapies has traded as high as $84.89 over the past 52 weeks
What Is Intra-Cellular Therapies’s 52-Week Low Share Price?
Intra-Cellular Therapies has traded as low as $45.50 over the past 52 weeks

Intra-Cellular Therapies Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Intra-Cellular Therapies?

How Much Debt Does Intra-Cellular Therapies Have?
Total long term debt quarterly is $0
How Much Cash Does Intra-Cellular Therapies Have?
Cash and short term investments quarterly total is $497.9M
What Is Intra-Cellular Therapies’s Book Value Per Share?
Book value per share is 6.14

Is Intra-Cellular Therapies Cash Flow Positive?

What Is ITCI Cash Flow From Operations?
Cash flow from operations (TTM) is -$124.2M
What Is Intra-Cellular Therapies’s Cash Flow From Financing?
Cash flow from financing (TTM) is $17.8M
What Is Intra-Cellular Therapies’s Cash Flow From Investing?
Cash flow from investing (TTM) is $105.5M

Intra-Cellular Therapies Return On Invested Capital

Is Management Doing A Good Job?
ITCI return on invested capital is -22.65%
What Is Intra-Cellular Therapies Return On Assets?
ROA measures how assets are converting to revenues and is -19.21%
What Is ITCI Return On Equity?
ROE is a measure of profitability and is -22.65%

Intra-Cellular Therapies Earnings Date & Stock Price

What Is Intra-Cellular Therapies's Stock Price Today?
A single share of ITCI can be purchased today for 73.26
What Is Intra-Cellular Therapies’s Stock Symbol?
Intra-Cellular Therapies trades on the nasdaq under the ticker symbol: ITCI
When Is Intra-Cellular Therapies’s Next Earnings Date?
The next quarterly earnings date for Intra-Cellular Therapies is scheduled on May 3, 2024
When Is ITCI's next ex-dividend date?
Intra-Cellular Therapies's next ex-dividend date is May 26, 2020
How To Buy Intra-Cellular Therapies Stock?
You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Intra-Cellular Therapies Competitors

Who Are Intra-Cellular Therapies's Competitors?
Below is a list of companies who compete with Intra-Cellular Therapies or are related in some way:
- ADMA Biologics Inc (ADMA)
- Fate Therapeutics Inc (FATE)
- Insmed Inc (INSM)
- Johnson & Johnson (JNJ)
- Vertex Pharmaceuticals Inc (VRTX)

Intra-Cellular Therapies Dividend Yield